We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$249M
(+11%)
Cap. Flow
+$50.8M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
1,560
New
411
Increased
288
Reduced
223
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$28.4M |
| 2 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$26.4M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$26M |
| 4 |
Theravance Biopharma
TBPH
|
+$25.2M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$46.1M |
| 2 |
RP
RealPage, Inc.
RP
|
+$26.3M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$15M |
| 4 |
Crown Holdings
CCK
|
+$14.2M |
| 5 |
QuantumScape Corp
QS
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.96% |
| 2 | Industrials | 4.3% |
| 3 | Technology | 4.06% |
| 4 | Financials | 3.71% |
| 5 | Communication Services | 2.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
PUT
Leidos
LDOS
$14.1B
| $222K | 0.01% |
+2,200
| New | +$226K |
|
902
LyondellBasell Industries
LYB
$19.5B
| $221K | 0.01% |
+2,149
| New | +$233K |
|
|
IPG
903
DELISTED
Interpublic Group of Companies
IPG
| $220K | 0.01% |
+6,757
| New | +$216K |
|
904
Parker-Hannifin
PH
$125B
| $220K | 0.01% |
+715
| New | +$221K |
|
905
Marvell Technology
MRVL
$174B
| $219K | 0.01% |
+3,763
| New | +$184K |
|
906
PUT
Whirlpool
WHR
$2.42B
| $218K | 0.01% |
+1,000
| New | +$233K |
|
|
CYT
907
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $217K | 0.01% |
+10,870
| New | +$204K |
|
908
PUT
Ameren
AEE
$31.5B
| $216K | 0.01% |
+2,700
| New | +$226K |
|
909
Centene
CNC
$31.3B
| $216K | 0.01% |
+2,966
| New | +$203K |
|
910
iPower
IPW
$1.27M
| $215K | 0.01% |
+113
| New | +$181K |
|
911
Microchip Technology
MCHP
$42.8B
| $215K | 0.01% |
2,878
-2,178
| -43% | -$166K |
|
912
Monte Rosa Therapeutics
GLUE
$1.92B
| $213K | 0.01% |
+11,106
| New | +$226K |
|
913
Lattice Semiconductor
LSCC
$17.6B
| $213K | 0.01% |
3,766
-3,035
| -45% | -$156K |
|
914
MetLife
MET
$61B
| $213K | 0.01% |
3,566
-1,364
| -28% | -$86.4K |
|
|
PIAI
915
DELISTED
Prime Impact Acquisition I
PIAI
| $213K | 0.01% |
21,800
-3,200
| -13% | -$31.3K |
|
916
Capital One
COF
$124B
| $212K | 0.01% |
1,368
-938
| -41% | -$142K |
|
917
PUT
Ventas
VTR
$48.9B
| $211K | 0.01% |
+3,700
| New | +$207K |
|
918
Full Truck Alliance
YMM
$9.56B
| $211K | 0.01% |
+12,000
| New | +$236K |
|
|
DAWN
919
DELISTED
Day One Biopharmaceuticals
DAWN
| $210K | 0.01% |
+9,000
| New | +$188K |
|
|
CNVY
920
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $210K | 0.01% |
+17,857
| New | +$207K |
|
921
PUT
United Airlines
UAL
$38.4B
| $209K | 0.01% |
4,000
-97,400
| -96% | -$5.4M |
|
|
ITCI
922
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $209K | 0.01% |
+5,100
| New | +$189K |
|
923
Monster Beverage
MNST
$91.4B
| $208K | 0.01% |
4,564
+1,306
| +40% | +$61.3K |
|
924
Medtronic
MDT
$107B
| $207K | 0.01% |
+1,664
| New | +$209K |
|
925
Nike
NKE
$61.9B
| $207K | 0.01% |
1,339
+108
| +9% | +$14.5K |
|
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q2 2021 Portfolio in Review
As of Q2 2021, Maven Securities held 1,560 positions worth $2.48B, up 11% from $2.23B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Maven Securities's Q2 2021 filing shows 411 new, 288 increased, 223 reduced and 552 closed positions. Its largest new stake was Proofpoint, Inc.: 175,167 shares worth $30.4M. The largest sale was Invesco QQQ Trust, an estimated $46.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Industrials and Technology.
- Maven Securities's largest Q2 2021 buy was Proofpoint, Inc.: 175,167 shares worth $30.4M.
- Maven Securities added most to Xilinx Inc in Q2 2021, an estimated $14.8M increase.
- Maven Securities's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $46.1M.
- Maven Securities fully exited RealPage, Inc. in Q2 2021, selling an estimated $26.3M.
- Maven Securities's ten largest holdings make up 26% of its $2.48B portfolio in Q2 2021.
- Maven Securities opened 411 new positions and closed 552 in Q2 2021.
- Maven Securities's portfolio value rose 11% quarter-over-quarter to $2.48B.
Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.